Jubilant Pharma

Noida, India Founded: 1978 • Age: 48 yrs
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
Annual revenue $42,308 Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Jubilant Pharma

Founded in 1978 and headquartered in Noida, India, the company operates in the pharmaceutical sector. Active pharmaceutical ingredients are produced for other firms, alongside generic and specialty drugs, including allergy therapies. Contract manufacturing is provided for parenteral products, ophthalmics, ointments, creams, and gels. Radiopharmaceuticals for nuclear medicine are specialized in, supported by a global pharmacy network. Finished dosage forms are supplied across various therapeutic areas.

Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $42.31 K (USD)
    0.03
    as on Mar 31, 2018
  • Net Profit
    $29.51 K (USD)
    8.39
    as on Mar 31, 2018
  • EBITDA
    -$2.73 K (USD)
    5.94
    as on Mar 31, 2018
  • Latest Funding Round
    $400 M (USD), Debt – Conventional

    Jul 14, 2022

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Jubilant Pharma

Headcount 1000-5000
Employee Profiles 21
Employee Profiles
People
Sarah Breland
Business Excellence Manager
People
Chris Preti
Chief Executive Officer
People
Elizabeth Arnold
Associate Director, PMO
People
Zied Damergi
Senior Project Manager

Unlock access to complete

Funding Insights of Jubilant Pharma

Investors in Jubilant Pharma

Jubilant Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Standard Chartered.

All
Institutional
Investor Description Founded Year Domain Location
Corporate, investment, wealth, and retail banking services are provided globally.
Locked Locked Locked
Premium access

Investor details for Jubilant Pharma

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Jubilant Pharma

Investments
Premium access

Investment portfolio details for Jubilant Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Jubilant Pharma

Premium access

Detailed financials for Jubilant Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Jubilant Pharma Comparisons

Jubilant Pharma Primary company
Description
Pharmaceuticals, APIs, and radiopharmaceuticals are manufact...
Location
Noida, India
Founded Year
1978
Annual Revenue
$42.31 K (USD)
Net Profit
$29.51 K (USD)
EBITDA
-$2.73 K (USD)
Employees
Not available
Premium access

Peer comparison for Jubilant Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Jubilant Pharma

Premium access

Detailed competitors of Jubilant Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Jubilant Pharma

Premium access

Complete news archive for Jubilant Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jubilant Pharma

Jubilant Pharma was founded in 1978 and raised its 1st funding round 41 years after it was founded.

Jubilant Pharma is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.

Annual revenue of Jubilant Pharma is $42.31K as on Mar 31, 2018.

Founded in 1978 and headquartered in Noida, India, the company operates in the pharmaceutical sector. Active pharmaceutical ingredients are produced for other firms, alongside generic and specialty drugs, including allergy therapies. Contract manufacturing is provided for parenteral products, ophthalmics, ointments, creams, and gels. Radiopharmaceuticals for nuclear medicine are specialized in, supported by a global pharmacy network. Finished dosage forms are supplied across various therapeutic areas.

Jubilant Pharma has 1 investor. Key investors include Standard Chartered.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available